Diagnostic Value of sST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis
Biomarkers such as B-type natriuretic peptide (BNP), N-terminal pro-BNP (NT-proBNP), cardiac troponin (cTn), and CK-MB contribute significantly to the diagnosis of cardiovascular disease (CVD). Recent studies have demonstrated that suppression of tumorigenicity 2 (ST2) is associated with CVD, but a...
Main Authors: | Tianyi Zhang, Chengyang Xu, Rui Zhao, Zhipeng Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.697837/full |
Similar Items
-
sST2 and Heart Failure—Clinical Utility and Prognosis
by: Magdalena Dudek, et al.
Published: (2023-04-01) -
Elevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis
by: Michael J. Coronado, et al.
Published: (2019-01-01) -
STADE‐HF (sST2 As a help for management of HF): a pilot study
by: Fabien Huet, et al.
Published: (2020-04-01) -
Prognostic Role of sST2 in Acute Heart Failure and COVID-19 Infection—A Narrative Review on Pathophysiology and Clinical Prospective
by: Luca Marino, et al.
Published: (2022-07-01) -
Multimarker approach including CRP, sST2 and GDF‐15 for prognostic stratification in stable heart failure
by: Nils Kuster, et al.
Published: (2020-10-01)